| Old Articles: <Older 8661-8670 Newer> |
|---|
 |
Chemistry World
August 27, 2013
Ian Le Guillou |
A golden answer to drug competition The golden ratio, first noted around 300BC by Euclid in his mathematical treatise The Elements, can be found across geometry, nature and now even pharmacology. The golden ratio could point the way for a simple method of determining competition between drugs.   |
Chemistry World
August 22, 2013
Phillip Broadwith |
J&J buys Aragon's prostate cancer arm Hormonally-driven cancer drug discovery specialist Aragon Pharmaceuticals has been bought by Johnson & Johnson. |
Chemistry World
August 21, 2013
Phillip Broadwith |
Two way traffic for Chinese drug licensing Chinese companies have trailed behind their Western counterparts in developing innovative new drugs. Very few of those inventions have been considered useful enough to be licensed by western companies. However, that appears to be changing. |
Chemistry World
August 20, 2013
Phillip Broadwith |
Boehringer to close manufacturing plants and cut jobs Boehringer Ingelheim is closing two US manufacturing plants, with a combined loss of 690 jobs. |
Chemistry World
August 19, 2013
Hepeng Jia |
Chinese drug watchdog set for major reforms China's slow drug approval process has been a cause for complaint for both Chinese subsidiaries of multinational pharmaceuticals and domestic drug developers. |
Chemistry World
August 16, 2013
Dinsa Sachan |
Indian U-turn on diabetes drug ban In June the Indian government suspended the popular diabetes drug, pioglitazone, over safety concerns only to revoke the suspension a little over a month later. |
Chemistry World
August 15, 2013
Lorenzo Caggiano |
An introduction to medicinal chemistry (5th edition) An introduction to medicinal chemistry, by Graham Patrick, is exactly that and more. It is an essential text aimed at undergraduates and postgraduates studying aspects of medicinal chemistry. |
Pharmaceutical Executive
August 1, 2013
William Looney |
Succinctly Shire: An Interview with CEO Flemming Ornskov Shire's new CEO has a simple strategy for success: Set the pace on specialty medicines, spread the positive buzz and momentum of a growth stock, and seize the opportunity to innovate. |
Pharmaceutical Executive
August 1, 2013
Peter Houston |
The Case for Content Reaching skittish consumers through objective, story driven information is digital marketing's hottest digit. But applying this consumer phenomenon in Big Pharma presents some unique challenges. |
Pharmaceutical Executive
August 1, 2013
Joseph Saba |
New Rules for a New Africa Declining revenue growth in the United States and Europe have sent pharmaceutical companies in search of opportunities in the BRICs and other emerging economies. Now, companies are finally turning their attention to Africa. |
| <Older 8661-8670 Newer> Return to current articles. |
